SupplementDrug
Muramidase clinical trials
Also written Lysozyme.
- studies test it
- 3
- open now
- 1
- in phase 3
- 1
- first study started
- 2012
Keep track of what changes. Save the Muramidase studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
3 studies that test it; most in 2012 (1)
| Year | Studies |
|---|---|
| 2012 | 1 |
| 2016 | 1 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 3
- 1
- Phase 4
- 1
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 2
Washington University School of Medicine (1) · Eisai Co., Ltd. (1) · University of Washington (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Muramidase is read from its arms, and is right about nine times in ten.
Testing it · 3
- Lactoferrin and Lysozyme Supplementation for Long-term Diarrhea SequelaeRecruitingPhase 3University of WashingtonNCT05519254Written as Lysozyme
- Lactoferrin and Lysozyme Supplementation for Environmental Enteric DysfunctionCompletedNot applicableWashington University School of MedicineNCT02925026Written as Lysozyme
- Pharmacological Effect of Lysozyme for Chronic Obstructive Pulmonary Disease and Asthma With Sputum SymptomCompletedPhase 4Eisai Co., Ltd.NCT01715493Written as lysozyme 90 mg
As the comparator · 1 — what is tested is compared with Muramidase
Codes
What other systems call Muramidase · ClinicalTrials.gg INT007856
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D009113 | Muramidase | One source ClinicalTrials.gov |
| RxNorm | 1426865 | — | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.